Related references
Note: Only part of the references are listed.DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
Laura Godfrey et al.
NATURE COMMUNICATIONS (2019)
Native internally calibrated chromatin immunoprecipitation for quantitative studies of histone post-translational modifications
Adrian T. Grzybowski et al.
NATURE PROTOCOLS (2019)
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development
Charles E. de Bock et al.
CANCER DISCOVERY (2018)
Examining the Roles of H3K4 Methylation States with Systematically Characterized Antibodies
Rohan N. Shah et al.
MOLECULAR CELL (2018)
STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
Daniel Ribeiro et al.
BLOOD ADVANCES (2018)
Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia
Hiroshi Okuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells
Jianwu Fang et al.
ONCOTARGET (2017)
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
Jon Kerry et al.
CELL REPORTS (2017)
MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches
Amanda C. Winters et al.
FRONTIERS IN PEDIATRICS (2017)
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Gabriele Nagel et al.
ANNALS OF HEMATOLOGY (2017)
PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease
Zejuan Li et al.
CANCER RESEARCH (2016)
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes
John P. McGrath et al.
CANCER RESEARCH (2016)
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Zizhen Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
STAT5 in Cancer and Immunity
Aradhana Rani et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2016)
Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells
Adam Collinson et al.
CELL REPORTS (2016)
New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia
Elias Jabbour et al.
CANCER (2015)
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Dmitry Borkin et al.
CANCER CELL (2015)
MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
Michael W. M. Kuehn et al.
HAEMATOLOGICA (2015)
The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated Methylation of H3K79
Shoudeng Chen et al.
MOLECULAR CELL (2015)
Calibrating ChIP-Seq with Nucleosomal Internal Standards to Measure Histone Modification Density Genome Wide
Adrian T. Grzybowski et al.
MOLECULAR CELL (2015)
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia
Chun-Wei Chen et al.
NATURE MEDICINE (2015)
HISAT: a fast spliced aligner with low memory requirements
Daehwan Kim et al.
NATURE METHODS (2015)
Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
Pierre Cauchy et al.
CELL REPORTS (2015)
MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
Michael W. M. Kuehn et al.
HAEMATOLOGICA (2015)
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
Alexa S. Green et al.
SCIENCE ADVANCES (2015)
Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16
Koki Ueda et al.
CANCER SCIENCE (2014)
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia
Fang Cao et al.
MOLECULAR CELL (2014)
Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome
David A. Orlando et al.
CELL REPORTS (2014)
PBX3 is an important cofactor of HOXA9 in leukemogenesis
Zejuan Li et al.
BLOOD (2013)
Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells
Bin E. Li et al.
BLOOD (2013)
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle et al.
BLOOD (2013)
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
Aniruddha J. Deshpande et al.
BLOOD (2013)
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
David I. Marks et al.
HAEMATOLOGICA (2013)
A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1 L
Justin L. Anglin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Histone H3K27 Trimethylation Inhibits H3 Binding and Function of SET1-Like H3K4 Methyltransferase Complexes
Dae-Hwan Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
A. Caldarelli et al.
LEUKEMIA (2013)
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
V. Grossmann et al.
LEUKEMIA (2013)
M-CSF instructs myeloid lineage fate in single haematopoietic stem cells
Noushine Mossadegh-Keller et al.
NATURE (2013)
The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
J. Shi et al.
ONCOGENE (2013)
RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction
Adam C. Wilkinson et al.
CELL REPORTS (2013)
Identification and characterization of Hoxa9 binding sites in hematopoietic cells
Yongsheng Huang et al.
BLOOD (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Asymmetrically Modified Nucleosomes
Philipp Voigt et al.
CELL (2012)
A potential therapeutic target for FLT3-ITD AML: PIM1 kinase
Amir T. Fathi et al.
LEUKEMIA RESEARCH (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Wenyu Yu et al.
NATURE COMMUNICATIONS (2012)
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
Stephanie Y. Jo et al.
BLOOD (2011)
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
Jianbiao Zhou et al.
BLOOD (2011)
Mechanisms of leukemogenesis by MLL fusion proteins
Rolf Marschalek
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks
Frank W. Schmitges et al.
MOLECULAR CELL (2011)
Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development
Michio Yamamoto et al.
PLOS ONE (2011)
Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study
Georg Mann et al.
BLOOD (2010)
Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
Ming-Jin Chang et al.
CANCER RESEARCH (2010)
Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)
Man Mohan et al.
GENES & DEVELOPMENT (2010)
Binding of the MLL PHD3 Finger to Histone H3K4me3 Is Required for MLL-Dependent Gene Transcription
Pei-Yun Chang et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis
Thomas A. Milne et al.
MOLECULAR CELL (2010)
Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)
David B. Rosen et al.
PLOS ONE (2010)
Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis
Lifeng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
Jianbiao Zhou et al.
BLOOD (2009)
Heterogeneous Nuclear Ribonucleoprotein L Is a Subunit of Human KMT3a/Set2 Complex Required for H3 Lys-36 Trimethylation Activity in Vivo
Wen Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c
Sandra Stehling-Sun et al.
NATURE IMMUNOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor
Katriina Peltola et al.
NEOPLASIA (2009)
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Matthew G. Guenther et al.
GENES & DEVELOPMENT (2008)
Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels
Albertus T. J. Wierenga et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment
M. C. Stubbs et al.
LEUKEMIA (2008)
Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4
Michiel Vermeulen et al.
CELL (2007)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
A chromatin landmark and transcription initiation at most promoters in human cells
Matthew G. Guenther et al.
CELL (2007)
Activation mechanisms of STAT5 by oncogenic Flt3-ITD
Chunaram Choudhary et al.
BLOOD (2007)
Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells
Malcolm A. S. Moore et al.
EXPERIMENTAL HEMATOLOGY (2007)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Persistent transactivation by Meis1 replaces Hox function in myeloid leukemogenesis models: Evidence for co-occupancy of Meis1-Pbx and Hox-Pbx complexes on promoters of leukemia-associated genes
GG Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL
M Adam et al.
CANCER RESEARCH (2006)
Overexpression of Pim-1 during progression of prostatic adenocarcinoma
TL Cibull et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements
DC Liang et al.
CANCER (2006)
Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications
TA Milne et al.
CANCER RESEARCH (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis
Y Du et al.
BLOOD (2005)
Signal transduction of oncogenic Flt3
C Choudhary et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
hDOT1L links histone methylation to leukemogenesis
Y Okada et al.
CELL (2005)
RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518
DK Walters et al.
BLOOD (2005)
Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis
R Ono et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression
FA Scheeren et al.
NATURE IMMUNOLOGY (2005)
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival
KT Kim et al.
BLOOD (2005)
MLL: a histone methyltransferase disrupted in leukemia
JL Hess
TRENDS IN MOLECULAR MEDICINE (2004)
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression
A Yokoyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5
K Paukku et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization
BB Zeisig et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote
D Schübeler et al.
GENES & DEVELOPMENT (2004)
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518
JJ Clark et al.
BLOOD (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/IETS oncoproteins
B Deneen et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Engineering de novo reciprocal chromosomal translocations associated with MII to replicate primary events of human cancer
A Forster et al.
CANCER CELL (2003)
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
M Mizuki et al.
BLOOD (2003)
FLT3 mutations in acute myeloid leukemia cell lines
H Quentmeier et al.
LEUKEMIA (2003)
Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1
KR Calvo et al.
ONCOGENE (2002)
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
M Levis et al.
BLOOD (2002)
COMPASS, a histone H3 (lysine 4) methyltransferase required for telomeric silencing of gene expression
NJ Krogan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells
K Spiekermann et al.
EXPERIMENTAL HEMATOLOGY (2002)
Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway
S Constantino et al.
ONCOGENE (2001)
Share Paper
